Pulmonary endemic mycoses.

Endemic mycoses Fungi Immunocompromised Infection Pulmonary

Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
Jan 2024
Historique:
medline: 4 3 2024
pubmed: 22 2 2024
entrez: 21 2 2024
Statut: ppublish

Résumé

While rare, the likelihood of encountering a case of a pulmonary endemic mycosis (PEM) in the UK is increasing. Diagnosis may be challenging, often leading to considerable delay to appropriate treatment. Clinical suspicion must be present for respiratory disease, particularly in the immunocompromised or in those not responding to empiric treatment approaches, and an extended travel history should be obtained. This article summarises the epidemiology of PEM, key clinical features, diagnostic strategies and management.

Identifiants

pubmed: 38382182
pii: S1470-2118(24)00002-2
doi: 10.1016/j.clinme.2024.100014
pmc: PMC11024832
pii:
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100014

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

Mycopathologia. 2021 Oct;186(5):697-705
pubmed: 34498137
Lancet Infect Dis. 2021 Dec;21(12):e364-e374
pubmed: 34364529
Diagnostics (Basel). 2021 May 10;11(5):
pubmed: 34068825
Clin Microbiol Infect. 2019 Feb;25(2):233-241
pubmed: 29698815
J Fungi (Basel). 2023 Feb 10;9(2):
pubmed: 36836350
Respiration. 2018;96(3):283-301
pubmed: 29953992
J Fungi (Basel). 2022 Aug 07;8(8):
pubmed: 36012812
Emerg Infect Dis. 2018 Mar;24(3):417-423
pubmed: 29460741
Int J Infect Dis. 1998 Jul-Sep;3(1):48-53
pubmed: 9831676
Mycopathologia. 2020 Oct;185(5):843-865
pubmed: 32040709
J Fungi (Basel). 2022 Oct 27;8(11):
pubmed: 36354899
Emerg Infect Dis. 2008 Jul;14(7):1053-9
pubmed: 18598625
J Fungi (Basel). 2023 Jun 06;9(6):
pubmed: 37367583
Infect Dis Ther. 2022 Apr;11(2):713-742
pubmed: 35233706
Emerg Infect Dis. 2009 Mar;15(3):397-401
pubmed: 19239751
Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):839-41
pubmed: 16315009
Emerg Infect Dis. 2006 Jun;12(6):958-62
pubmed: 16707052

Auteurs

Michael J Wilson (MJ)

SpR in infectious diseases and microbiology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK. Electronic address: michael.wilson@uhbw.nhs.uk.

Irasha Harding (I)

consultant microbiologist, National Infection Service, Bristol, UK.

Andrew M Borman (AM)

deputy director, UKHSA National Mycology Reference Laboratory, Bristol, UK; honorary professor of medical mycology, University of Exeter, Exeter, UK.

Elizabeth Johnson (E)

honorary professor of medical mycology, University of Exeter, Exeter, UK; director, UKHSA National Mycology Reference Laboratory, Bristol, UK.

Robert Miller (R)

Associate Professor of Clinical Infection, Institute for Global Health, University College London.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH